Inactive Instrument

Analyst Reco. Cadila Healthcare Limited Bombay S.E.

Equities

CADI

INE010B01019

End-of-day quote Bombay S.E. Other stock markets
- ^INR	-

May. 27	Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research	RE
May. 24	Zydus Completes Patient Enrolment for Phase II Clinical Trial of Usnoflast in ALS Patients	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Nomura Downgrades Zydus Lifesciences to Neutral From Buy, Adjusts Price Target to INR1,020 From INR988	May. 21	MT
Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,070 From INR750, Keeps at Hold	May. 20	MT
Jefferies Adjusts Zydus Lifesciences’ Price Target to INR750 From INR660, Keeps at Hold	Feb. 12	MT
Indian shares set for a muted start, tracking Asian peers	Feb. 08	RE
India's Nifty set to open with slight gains, tracking Asia	Dec. 25	RE
Jefferies Adjusts Zydus Lifesciences’ Price Target to INR640 From INR630, Keeps at Hold	Nov. 08	MT
Indian Equities Close Higher on Friday as Major Central Banks Hold Rates Steady	Nov. 03	MT
Indian shares set for muted start as Fed rate worries, China concerns weigh	23-08-17	RE
Nomura Adjusts Zydus Lifesciences' Price Target to INR747 From INR540, Keeps at Buy	23-08-15	MT
Jefferies Downgrades Zydus Lifesciences to Hold From Buy, Adjusts Price Target to INR630 From INR585	23-08-14	MT
Indian shares set for muted open ahead of June quarter earnings	23-07-09	RE
Indian shares set to open higher on Fed rate pause optimism	23-06-13	RE
Jefferies Adjusts Zydus Lifesciences' Price Target to INR585 From INR575, Keeps at Buy	23-05-19	MT
Indian shares to open lower on weak earnings, Fed rate hike worries	23-04-16	RE
Indian shares set to fall on rate fears ahead of U.S. jobs data	23-03-09	RE
Indian shares set to fall on rate fears after Powell's testimony	23-03-07	RE
Indian shares set to open lower on Q3 growth slowdown, weak global cues	23-02-28	RE
Nomura Adjusts Zydus Lifesciences' Price Target to INR540 From INR489, Keeps at Buy	23-02-07	MT
Crisil Affirms AA+ Rating on Zydus Lifesciences' Bank Loans; Outlook Stable	23-01-11	MT
Indian shares tipped to fall ahead Nov inflation data	22-12-11	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Cadila Healthcare Limited Bombay S.E.

Equities

CADI

INE010B01019

Analyst Reco.

Filters